Your browser is no longer supported. Please, upgrade your browser.
Midatech Pharma plc
Index- P/E- EPS (ttm)-0.90 Insider Own0.21% Shs Outstand12.66M Perf Week6.51%
Market Cap34.83M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float10.10M Perf Month-0.55%
Income-10.80M PEG- EPS next Q- Inst Own7.80% Short Float1.46% Perf Quarter-5.76%
Sales0.80M P/S43.54 EPS this Y-3.90% Inst Trans0.47% Short Ratio1.20 Perf Half Y-6.77%
Book/sh0.41 P/B4.39 EPS next Y- ROA-52.00% Target Price- Perf Year-18.92%
Cash/sh0.29 P/C6.11 EPS next 5Y- ROE-91.70% 52W Range1.62 - 3.83 Perf YTD-3.74%
Dividend- P/FCF- EPS past 5Y- ROI-309.90% 52W High-53.00% Beta2.63
Dividend %- Quick Ratio1.80 Sales past 5Y- Gross Margin- 52W Low11.11% ATR0.07
Employees18 Current Ratio1.80 Sales Q/Q-20.00% Oper. Margin- RSI (14)54.37 Volatility5.44% 3.83%
OptionableNo Debt/Eq0.22 EPS Q/Q83.00% Profit Margin- Rel Volume1.50 Prev Close1.85
ShortableYes LT Debt/Eq0.18 Earnings- Payout- Avg Volume123.24K Price1.80
Recom- SMA202.74% SMA501.30% SMA200-13.43% Volume184,378 Change-2.70%
Sep-06-21 02:00AM  
Jul-12-21 09:50AM  
Jun-29-21 09:01AM  
Jun-17-21 08:35AM  
Jun-09-21 02:00AM  
May-21-21 11:15AM  
May-17-21 04:35AM  
Apr-30-21 10:15AM  
Mar-25-21 07:58AM  
Feb-17-21 02:00AM  
Dec-11-20 12:15PM  
Nov-24-20 02:00AM  
Oct-19-20 02:00AM  
Sep-10-20 02:00AM  
Sep-07-20 06:20AM  
Aug-28-20 02:00AM  
Aug-19-20 02:00AM  
Aug-14-20 02:00AM  
Jul-23-20 02:00AM  
Jul-03-20 02:00AM  
Jun-30-20 09:40AM  
Jun-24-20 12:18PM  
Jun-17-20 02:00AM  
Jun-16-20 02:00AM  
Jun-09-20 11:35AM  
May-22-20 06:00AM  
May-21-20 02:01AM  
May-19-20 07:15AM  
May-18-20 10:20AM  
May-12-20 12:55PM  
May-01-20 07:00AM  
Apr-22-20 11:30AM  
Apr-20-20 01:10PM  
Mar-31-20 02:00AM  
Mar-02-20 11:25AM  
Feb-12-20 09:50AM  
Jan-08-20 08:12AM  
Dec-17-19 07:56AM  
Dec-16-19 06:20PM  
Dec-05-19 09:10AM  
Nov-14-19 05:54AM  
Oct-28-19 03:05AM  
Jul-19-19 03:24PM  
May-09-19 10:30AM  
Feb-27-19 10:00AM  
Jan-29-19 06:42AM  
Dec-11-18 03:17AM  
Oct-10-18 04:28AM  
Oct-03-18 11:00AM  
Sep-27-18 07:00AM  
Sep-18-18 06:36AM  
Sep-07-18 10:30AM  
Aug-31-18 07:00AM  
Jul-25-18 07:00AM  
Jul-23-18 09:23AM  
Jun-08-18 02:00AM  
May-29-18 02:51PM  
May-25-18 07:00AM  
May-03-18 08:20AM  
Apr-27-18 09:45AM  
Mar-23-18 03:32AM  
Mar-15-18 08:01AM  
Mar-07-18 10:15AM  
Feb-28-18 07:00AM  
Feb-14-18 07:00AM  
Jan-16-18 07:01AM  
Jan-12-18 12:00PM  
Nov-27-17 03:00PM  
Oct-27-17 01:59PM  
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.